General Information of the Compound
Compound ID |
CP0477396
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
8-(4-propylpiperazin-1-yl)-2,3-dihydro-1,4-benzodioxin-5-ol
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C15H22N2O3
|
||||||||||||||||||
Molecular Weight |
278.352
|
||||||||||||||||||
Canonical SMILES |
CCCN1CCN(CC1)c1ccc(O)c2OCCOc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C15H22N2O3/c1-2-5-16-6-8-17(9-7-16)12-3-4-13(18)15-14(12)19-10-11-20-15/h3-4,18H,2,5-11H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
AIANRSPJEBRESY-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01169, D(1B) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor